Modulation of neuropathic pain by a glial-derived factor

Pain Medicine

Volumn 10, Issue 7, 2009, Pages 1229-1236

  Adler, Joshua E ^a,b   Nico, Lindsey ^b   VandeVord, Pamela ^a,b   Skoff, Anne M ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allodynia; GDNF; Neuropathic Pain; Somatostatin

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; SOMATOSTATIN; ANALGESIC AGENT;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DORSAL ROOT; DRUG EFFECT; DRUG EFFICACY; FEMALE; NERVE INJURY; NEUROPATHIC PAIN; NONHUMAN; PROTEIN EXPRESSION; RAT; SENSORY NERVE CELL; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME; ANIMAL; DELAYED RELEASE FORMULATION; INTRASPINAL DRUG ADMINISTRATION; METHODOLOGY; NEURALGIA; PAIN ASSESSMENT; PATHOPHYSIOLOGY;

ANALGESICS; ANIMALS; DELAYED-ACTION PREPARATIONS; FEMALE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; INJECTIONS, SPINAL; NEURALGIA; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 73949129835     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2009.00708.x     Document Type: Article

References (52)

1. Meyer RA, Campell JN. Peripheral neural mechanisms of nociception. Textbook of Pain 1994, 13-44. Wall PD, Meltzack R. eds., London, Churchill Livingston
2. Simone DA, Sorkin LS, Oh U, Chung JM. Neurogenic hyperalgesia: Central neural correlates in responses of spinothalamic tract neurons. J Neurophysiol 1991, 66(1):228-46.
3. DeLeo JA, Colburn RW, Rickman AJ. Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy. Brain Res 1997, 759(1):50-7.
4. Skoff AM, Zhao C, Adler JE. Interleukin-1alpha regulates substance P expression and release in adult sensory neurons. Exp Neurol 2009
5. Furukawa S, Furukawa Y, Satoyoshi E, Hayashi K. Synthesis and secretion of nerve growth factor by mouse astroglial cells in culture. Biochem Biophys Res Commun 1986, 136(1):57-63.
6. Yamakuni T, Ozawa F, Hishinuma F. Expression of beta-nerve growth factor mRNA in rat glioma cells and astrocytes from rat brain. FEBS Lett 1987, 223(1):117-21.
7. Condorelli DF, Salin T, Albani D. Neurotrophins and their trk receptors in cultured cells of the glial lineage and in white matter of the central nervous system. J Mol Neurosci 1995, 6(4):237-48.
8. Lewin GR, Ritter AM, Mendell LM. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J Neurosci 1993, 13(5):2136-48.
9. Zhou XF, Deng YS, Xian CJ, Zhong JH. Neurotrophins from dorsal root ganglia trigger allodynia after spinal nerve injury in rats. Eur J Neurosci 2000, 12(1):100-5.
10. Petty BG, Cornblath DR, Adornato BT. The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann Neurol 1994, 36(2):244-6.
11. Boucher TJ, Okuse K, Bennett DL. Potent analgesic effects of GDNF in neuropathic pain states. Science 2000, 290(5489):124-7.
12. Decosterd I, Woolf CJ. Spared nerve injury: An animal model of persistent peripheral neuropathic pain. Pain 2000, 87(2):149-58.
13. Dixon WJ. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 1980, 20:441-62.
14. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994, 53(1):55-63.
15. Pogatzki EM, Zahn PK, Brennan TJ. Lumbar catheterization of the subarachnoid space with a 32-gauge polyurethane catheter in the rat. Eur J Pain 2000, 4(1):111-13.
16. Arimura A, Lundqvist G, Rothman J. Radioimmunoassay of somatostatin. Metabolism 1978, 27(1):1139-44. suppl
17. Adler JE. Age-dependent differential regulation of sensory neuropeptides by glial cell line-derived neurotrophic factor. J Neurochem 1998, 71(1):170-7.
18. Tessler A, Himes BT, Krieger NR, Murray M, Goldberger ME. Sciatic nerve transection produces death of dorsal root ganglion cells and reversible loss of substance P in spinal cord. Brain Res 1985, 332(2):209-18.
19. Lindenlaub T, Sommer C. Partial sciatic nerve transection. Methods Mol Med 2004, 99:47-53.
20. Bennett DL, Michael GJ, Ramachandran N. A distinct subgroup of small DRG cells express GDNF receptor components and GDNF is protective for these neurons after nerve injury. J Neurosci 1998, 18(8):3059-72.
21. Kuraishi Y, Hirota N, Sato Y. Evidence that substance P and somatostatin transmit separate information related to pain in the spinal dorsal horn. Brain Res 1985, 325(1-2):294-8.
22. Morton CR, Hutchison WD, Hendry IA, Duggan AW. Somatostatin: Evidence for a role in thermal nociception. Brain Res 1989, 488(1-2):89-96.
23. Seybold VS, Hylden JL, Wilcox GL. Intrathecal substance P and somatostatin in rats: Behaviors indicative of sensation. Peptides 1982, 3(1):49-54.
24. Kamei J, Hitosugi H, Misawa M, Nagase H, Kasuya Y. Cold water swim stress inhibits the nociceptive responses to intrathecally administered somatostatin, but not substance P. Life Sci 1993, 52(17):PL169-74.
25. Gaumann DM, Yaksh TL, Post C, Wilcox GL, Rodriguez M. Intrathecal somatostatin in cat and mouse studies on pain, motor behavior, and histopathology. Anesth Analg 1989, 68(5):623-32.
26. Mollenholt P, Post C, Paulsson I, Rawal N. Intrathecal and epidural somatostatin in rats: Can antinociception, motor effects and neurotoxicity be separated? Pain 1990, 43(3):363-70.
27. Chrubasik J, Meynadier J, Blond S. Somatostatin, a potent analgesic. Lancet 1984, 2(8413):1208-9.
28. Chrubasik J, Meynadier J, Scherpereel P, Wunsch E. The effect of epidural somatostatin on postoperative pain. Anesth Analg 1985, 64(11):1085-8.
29. Penn RD, Paice JA, Kroin JS. Octreotide: a potent new non-opiate analgesic for intrathecal infusion. Pain 1992, 49(1):13-19.
30. Beltrutti DP, Moessinger S, Varrassi G. The epidural and intrathecal administration of somatotrophin-release inhibiting factor: Native and synthetic analogues. Curr Rev Pain 2000, 4(1):82-90.
31. Eschalier A, Aumaitre O, Ardid D, Fialip J, Duchene-Marullaz P. Long-lasting antinociceptive effect of RC-160, a somatostatin analog, in mice and rats. Eur J Pharmacol 1991, 199(1):119-21.
32. Chapman V, Dickenson AH. The effects of sandostatin and somatostatin on nociceptive transmission in the dorsal horn of the rat spinal cord. Neuropeptides 1992, 23(3):147-52.
33. Betoin F, Eschalier A, Duchene-Marullaz P, Lavarenne J. Seven-day antinociceptive effect of a sustained release vapreotide formulation. Neuroreport 1994, 5(5):642-4.
34. Ono N, Kroin JS, Penn RD, Paice JA. Effects of intrathecal nonnarcotic analgesics on chronic tactile allodynia in rats: Alpha 2-agonists versus somatostatin analog. Neurol Med Chir (Tokyo) 1997, 37(1):6-10. discussion 10-11
35. Epelbaum J. Somatostatin in the central nervous system: Physiology and pathological modifications. Prog Neurobiol 1986, 27(1):63-100.
36. Reisine T. Somatostatin. Cell Mol Neurobiol 1995, 15(6):597-614.
37. Guillemin R. Somatostatin inhibits the release of acetylcholine induced electrically in the myenteric plexus. Endocrinology 1976, 99(6):1653-4.
38. Cohen ML, Rosing E, Wiley KS, Slater IH. Somatostatin inhibits adrenergic and cholinergic neurotransmission in smooth muscle. Life Sci 1978, 23(16):1659-64.
39. Maynard KI, Saville VL, Burnstock G. Somatostatin modulates vascular sympathetic neurotransmission in the rabbit ear artery. Eur J Pharmacol 1991, 196(2):125-31.
40. Green PG, Basbaum AI, Levine JD. Sensory neuropeptide interactions in the production of plasma extravasation in the rat. Neuroscience 1992, 50(3):745-9.
41. Lawson S. Morphological and biochemical cell types of sensory neurons. Sensory Neurons: Diversity, Development and Plasticity 1992, 27-59. Scott AA. In, ed., New York, NY, Oxford University Press
42. Choi-Lundberg DL, Bohn MC. Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat. Brain Res Dev Brain Res 1995, 85(1):80-8.
43. Hammarberg H, Piehl F, Cullheim S. Schwann cells and DRG satellite cells after chronic sciatic nerve injury. Neuroreport 1996, 7(4):857-60.
44. Kashiba H, Hyon B, Senba E. Glial cell line-derived neurotrophic factor and nerve growth factor receptor mRNAs are expressed in distinct subgroups of dorsal root ganglion neurons and are differentially regulated by peripheral axotomy in the rat. Neurosci Lett 1998, 252(2):107-10.
45. Holstege JC, Jongen JL, Kennis JH, van Rooyen-Boot AA, Vecht CJ. Immunocytochemical localization of GDNF in primary afferents of the lumbar dorsal horn. Neuroreport 1998, 9(12):2893-7.
46. Widenfalk J, Widmer HR, Spenger C. GDNF, RET and GFRalpha-1-3 mRNA expression in the developing human spinal cord and ganglia. Neuroreport 1999, 10(7):1433-9.
47. Honda T, Takahashi M, Sugiura Y. Co-localization of the glial cell-line derived neurotrophic factor and its functional receptor c-RET in a subpopulation of rat dorsal root ganglion neurons. Neurosci Lett 1999, 275(1):45-8.
48. Jongen JL, Dalm E, Vecht CJ, Holstege JC. Depletion of GDNF from primary afferents in adult rat dorsal horn following peripheral axotomy. Neuroreport 1999, 10(4):867-71.
49. Verge VM, Richardson PM, Wiesenfeld-Hallin Z, Hokfelt T. Differential influence of nerve growth factor on neuropeptide expression in vivo: A novel role in peptide suppression in adult sensory neurons. J Neurosci 1995, 15(3):2081-96. Pt 1
50. Nagano M, Sakai A, Takahashi N. Decreased expression of glial cell line-derived neurotrophic factor signaling in rat models of neuropathic pain. Br J Pharmacol 2003, 140(7):1252-60.
51. Dong ZQ, Wang YQ, Ma F, Xie H, Wu GC. Down-regulation of GFRalpha-1 expression by antisense oligodeoxynucleotide aggravates thermal hyperalgesia in a rat model of neuropathic pain. Neuropharmacology 2005
52. Hao S, Mata M, Wolfe D. V-mediated gene transfer of the glial cell-derived neurotrophic factor provides an antiallodynic effect on neuropathic pain. Mol Ther 2003, 8(3):367-75.